T1dm Flashcards
definition opf T1dm
metabolic hyperglycaemic condition
caused by absolute insufficiency of pancreatic insulin production
aetiology of T1dm
destruction of insulin producing B cells = insulin deficiency
autoimmune in 90%
genetically susceptable patinets and triggered by env (low concordance in identical twins)
polymorphisms of genes influence the risk - gene encoding preproinsulin and HLA-DQB and HLA-DR, PTPN22 and CTLA-4
gene 6q determines islet sensitivity to damage eg from viruses or cross-reactivity from cow’s milk induced Ab
pancreatic B cell autoantigens involved in initiation or progression of autoimmune islet injury - include: glutamic acid decarboxylase, insulin, insulinoma-associated protein 2 (IA-2) and cation efflux zinc transporter (ZnT8)
secondary dm
- steroids
- anti-HIV drugs
- newer antipsychotics
- protease inhibitors
- pancreatic - pancreatitis, surgery, trauma, pancreatic destruction (eg haemochromatosis, CF), pancreatic ca
- cushing’s disease
- acromegaly
- phaeo
- hyperthyroidism
- glucagonoma
- pregnancy
- congenital lipodystrophy, glycogen storage diseases
- glycogen storage diseases
epidemiology of T1dm
one of the most common chronic diseases in childhood with a prevalence of 0.25% in the UK
usually adolescent, can effect any age
geographic variation
US and northern europe incidence - 8-17/100000 per yr
signs and sx of T1dm
juvenille onset < 30yrs
polyuria/nocturia - osmotic diuresis caused by glycosuria
polydipsia (thirst)
tiredness
weight loss
sx and signs of complications
signs of associated autoimmune conditions
sx and signs of diabetic ketoacidosis
- nausea
- vomiting
- abdo pain
- polyuria
- polydipsia
- drowsiness
- confusion
- coma
- kussmaul breathing - deep and rapid
- ketotic breath
- signs of dehydration - dry mucous membranes, reduced tissue turgor
signs of T1dm complications
fundoscopy - dm retinopathy
examination of feet - neuropathy - 10g monofilament testing and vibration sensation, pulses - dorsalis pedis and posterior tibial pulses
BP
signs of associated autoimmune conditions
vitiligo
Addison’s disease
autoimmune thyroid disease
Ix for T1dm
blood glucose - fasting >7mmol/L or random >11mmol/L - 2 +ve results needed
HbA1c - overall glucose for 2-3mo
FBC - MCV, reticulocytes (increased erythrocyte turnover causes misleading HBa1c)
UE - nephropathy and hyperkalaemia from ACEi
lipid profile
urine albumin creatinine ratio - detect microalbuminuria
urine - glycosuria, high ketones, MSU (microscopy and culture)
CXR - exclude infection
ECG - acute ischemic changes
Ix for pts presenting with suspected DKA
- FBC - high WCC even w/o infection
- UE - high urea and creatinine from dehydration
- LFT
- CRP
- glucose
- amylase may be high
- blood cultures
- ABG - metabolic acidosis with high anion gap
- blood/urinary ketones
Mx of diabetic ketoacidosis
consider HDU/ICU input
central line, arterial line and urinary catheter if server acidosis, hypotensive or oliguric
insulin
fluids
K replacement
monitor blood glucose capillary ketones and UO hourly, UEs 4 hourly VBG at 0. 2.4. 8. 12h and before stopping fixed rate insulin. Monitor phos and mg daily
broad spectrum AB if infection suspected
thromboprophylaxis
NBM for at least 6hr - gastroparesis is common
NG tube if GCS is reduced to prevent vomiting and aspiration
insulin mx in DKA
50U of soluble insulin in 50mL 0.9% saline
start at 0.1U/Kg/h until capillary ketones <0.3, venous pH >7.3 and venous bicarb >18mmol/L
if pt able to drink change to SC insulin
if not - insulin sliding scale
dont stop infusion until 1-2hr after regular SC insulin is restarted
fluid Mx in DKA
500mL 0.9% saline over 15-30min until systolic BP is >100mmHg
then 1L 2hrly x3 and 1L 3hrly x3
IV dextrose when glucose reaches 15mmol/L:
- 1L 5% dextrose over 8hrs when blood glucose is 7-15mmol/L
- 500mL 10% dextrose over 4h when blood glucose <7mmol/L
K replacement for DKA
start in the second fluid bag if passing urine
adjust amount of K accoriding to the plasma K
- if >5.5mmol/l = none
- iof 2.5-5.5 mmol/L = 40mmol/L
- if <2.5mmol/L = 60-80mmol/L
glycaemic control in T1dm
advice and pt education - nurse specialists and dieticiants
self adjust doses based on exercise, glucose, calorie intake and carb counting
avoid binge drinking - danger of delayed hyperglycaemia
SC insulin - short acting (Lispro, aspart, glulisine) 3x daily before meals and one long acting (isophane, glargine, getemir) once daily. Rotate injection sites
insulin pumps may give better control - but expensive and cumbersome and DKA may occur if pump malfunctions - give if attempts to reach HbA1c = hypoglycaemia or person unable to meet target
DAFNE (dose adjustment for normal eating) - calculate carb intake and adjust dose accordingly
monitor - sx, regular finger prick tests, monitor HbA1c (target <7%) every 3-6mo
screening and Mx of complications and cardiovascular risk